Cargando…
Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma
AIM: To elucidate the effect of expression of doublecortin and CaM kinase-like-1 (DCLK1) in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Tumor specimens were obtained from 136 patients with pancreatic cancer who had undergone resection without preoperative therapy between January...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569291/ https://www.ncbi.nlm.nih.gov/pubmed/28883702 http://dx.doi.org/10.3748/wjg.v23.i31.5764 |
_version_ | 1783258964165656576 |
---|---|
author | Nishio, Kohei Kimura, Kenjiro Amano, Ryosuke Nakata, Bunzo Yamazoe, Sadaaki Ohira, Go Miura, Kotaro Kametani, Naoki Tanaka, Hiroaki Muguruma, Kazuya Hirakawa, Kosei Ohira, Masaichi |
author_facet | Nishio, Kohei Kimura, Kenjiro Amano, Ryosuke Nakata, Bunzo Yamazoe, Sadaaki Ohira, Go Miura, Kotaro Kametani, Naoki Tanaka, Hiroaki Muguruma, Kazuya Hirakawa, Kosei Ohira, Masaichi |
author_sort | Nishio, Kohei |
collection | PubMed |
description | AIM: To elucidate the effect of expression of doublecortin and CaM kinase-like-1 (DCLK1) in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Tumor specimens were obtained from 136 patients with pancreatic cancer who had undergone resection without preoperative therapy between January 2000 and December 2013 at the Department of Surgical Oncology, Osaka City University. The resected specimens were analyzed for associations with clinicopathological data, including DCLK1 expression, epithelial mesenchymal transition (EMT) marker expression, and cancer stem cell (CSC) marker expression. Univariate and multivariate survival analyses were performed and we assessed the association between DCLK1 expression and clinicopathological factors, including the EMT marker and CSC marker. RESULTS: In total, 48.5% (66/136) of the pancreatic cancer samples were positive for DCLK1. Patients with DCLK1-positive tumors had significantly shorter survival times than those with DCLK1-negative tumors (median, 18.7 mo vs 49.5 mo, respectively; P < 0.0001). Positive DCLK1 expression correlated with histological grade (P = 0.0290), preoperative CA19-9 level (P = 0.0060), epithelial cell adhesion molecule (EpCAM) expression (P = 0.0235), and the triple-positive expression of CD44/CD24/EpCAM (P = 0.0139). On univariate survival analysis, five factors were significantly associated with worse overall survival: histological grade of G2 to G4 (P = 0.0091), high preoperative serum SPan-1 level (P = 0.0034), R1/2 (P < 0.0001), positive expression of DCLK1 (P < 0.0001) or CD44 (P = 0.0245). On multivariate survival analysis, R1/2 [odds ratio (OR) = 2.019, 95% confidence interval (CI): 1.380-2.933; P = 0.0004] and positive DCLK1 expression (OR = 1.848, 95%CI: 1.2854-2.661; P = 0.0009) were independent prognostic factors. CONCLUSION: DCLK1 expression was found to be an independent prognostic factor and it may play a crucial prognostic role by promoting acquisition of stemness. |
format | Online Article Text |
id | pubmed-5569291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-55692912017-09-07 Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma Nishio, Kohei Kimura, Kenjiro Amano, Ryosuke Nakata, Bunzo Yamazoe, Sadaaki Ohira, Go Miura, Kotaro Kametani, Naoki Tanaka, Hiroaki Muguruma, Kazuya Hirakawa, Kosei Ohira, Masaichi World J Gastroenterol Retrospective Study AIM: To elucidate the effect of expression of doublecortin and CaM kinase-like-1 (DCLK1) in patients with pancreatic ductal adenocarcinoma (PDAC). METHODS: Tumor specimens were obtained from 136 patients with pancreatic cancer who had undergone resection without preoperative therapy between January 2000 and December 2013 at the Department of Surgical Oncology, Osaka City University. The resected specimens were analyzed for associations with clinicopathological data, including DCLK1 expression, epithelial mesenchymal transition (EMT) marker expression, and cancer stem cell (CSC) marker expression. Univariate and multivariate survival analyses were performed and we assessed the association between DCLK1 expression and clinicopathological factors, including the EMT marker and CSC marker. RESULTS: In total, 48.5% (66/136) of the pancreatic cancer samples were positive for DCLK1. Patients with DCLK1-positive tumors had significantly shorter survival times than those with DCLK1-negative tumors (median, 18.7 mo vs 49.5 mo, respectively; P < 0.0001). Positive DCLK1 expression correlated with histological grade (P = 0.0290), preoperative CA19-9 level (P = 0.0060), epithelial cell adhesion molecule (EpCAM) expression (P = 0.0235), and the triple-positive expression of CD44/CD24/EpCAM (P = 0.0139). On univariate survival analysis, five factors were significantly associated with worse overall survival: histological grade of G2 to G4 (P = 0.0091), high preoperative serum SPan-1 level (P = 0.0034), R1/2 (P < 0.0001), positive expression of DCLK1 (P < 0.0001) or CD44 (P = 0.0245). On multivariate survival analysis, R1/2 [odds ratio (OR) = 2.019, 95% confidence interval (CI): 1.380-2.933; P = 0.0004] and positive DCLK1 expression (OR = 1.848, 95%CI: 1.2854-2.661; P = 0.0009) were independent prognostic factors. CONCLUSION: DCLK1 expression was found to be an independent prognostic factor and it may play a crucial prognostic role by promoting acquisition of stemness. Baishideng Publishing Group Inc 2017-08-21 2017-08-21 /pmc/articles/PMC5569291/ /pubmed/28883702 http://dx.doi.org/10.3748/wjg.v23.i31.5764 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Retrospective Study Nishio, Kohei Kimura, Kenjiro Amano, Ryosuke Nakata, Bunzo Yamazoe, Sadaaki Ohira, Go Miura, Kotaro Kametani, Naoki Tanaka, Hiroaki Muguruma, Kazuya Hirakawa, Kosei Ohira, Masaichi Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
title | Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
title_full | Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
title_fullStr | Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
title_full_unstemmed | Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
title_short | Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
title_sort | doublecortin and cam kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma |
topic | Retrospective Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569291/ https://www.ncbi.nlm.nih.gov/pubmed/28883702 http://dx.doi.org/10.3748/wjg.v23.i31.5764 |
work_keys_str_mv | AT nishiokohei doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT kimurakenjiro doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT amanoryosuke doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT nakatabunzo doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT yamazoesadaaki doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT ohirago doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT miurakotaro doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT kametaninaoki doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT tanakahiroaki doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT mugurumakazuya doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT hirakawakosei doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma AT ohiramasaichi doublecortinandcamkinaselike1asanindependentprognosticfactorinpatientswithresectedpancreaticcarcinoma |